Bioventrix Inc

Businessfiled

Bioventrix Inc operates in Other, based in MANSFIELD.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Bioventrix Inc has raised $191M in disclosed capital across 23 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $41M on 2020-12-21.

Most recent recorded round closed around 2024-10-10.

Filings read as a recurring offering program rather than a clean venture-stage ladder — interpret stage labels and step-ups with that in mind.

Valuation (modeled)modeled

Provath models Bioventrix Inc at approximately $21M (range $9.0M–$35M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.13× the median modeled value of Series B Other companies in 2022–2024 (465 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 3 months.

Last raise 21 mo ago; this sector typically re-raises about every 11 months.

Slightly overdue versus sector cadence.

The last round was 53.4× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 98% of Other peers (25015 compared).

Modeled value ranks above 54% of those peers.

Closest niche peers: Ever/Body, Inc., Financeware Holdings LLC, American Cricket Enterprises Inc., Xlerate Ultimate Holdings, Lp, MDME Ultimate Holdings, LP.

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.

Recurring-offering pattern: stage-based valuation has lower applicability.